pocketful logo
Unichem Laboratories Ltd logo

Unichem Laboratories Ltd

NSE: UNICHEMLAB BSE: 506690

₹390.10

(3.94%)

Sat, 02 May 2026, 05:04 pm

Unichem Laboratories Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    2740.90

  • Net Profit

    137.52

  • P/B

    1.99

  • Sector P/E

    33.38

  • P/E

    35.47

  • EV/EBITDA

    17.39

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.69

  • ROCE (Industry)

    13.46

  • RONW (Industry)

    12.65

  • ROE

    5.63

  • ROCE

    6.19

  • Debt/Equity

    0.14

  • EPS (TTM)

    14.94

  • Dividend Yield

    0

  • Book Value

    345.83

  • Interest Cover

    8.35

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Unichem Laboratories's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Unichem Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Unichem Laboratories has been profitable on average in the past, therefore cash runway is not a concern.
  • Unichem Laboratories has been profitable on average in the past, therefore cash runway is not a concern.
thumbs up icon

Cons

  • The company is paying a dividend however it is incurring a loss.
  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Unichem Laboratories's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Operating cash flow is negative therefore debt is not well covered.
  • The level of debt compared to net worth has increased over the past 5 years (2.7% vs 7.3% today).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters70.2270.2270.2270.2270.22
FII1.000.991.000.980.98
DII10.6310.7410.7510.9211.32
Public18.1518.0518.0317.8817.48
Government00000

Read More

Technical Analysis

RSI

68.04

MACD

14.38

50 DMA

337.34

200 DMA

445.22

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic446.73376.68335.07306.63265.02236.58166.53
Fibonacci376.68349.92333.39306.63279.87263.34236.58
Camarilla312.71306.29299.87306.63287.03280.61274.19

Pivots Level: Classic

R3

+140.10

446.73

R2

+70.05

376.68

R1

+28.43

335.07

306.63
306.63
Pivot Point
LTP: 390.10

S1

-41.62

265.02

S2

-70.05

236.58

S3

-140.10

166.53

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    367.98

  • 20-EMA

    354.06

  • 30-EMA

    348.79

  • 50-EMA

    351.66

  • 100-EMA

    378.86

  • 200-EMA

    434.50

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
05 Feb 2026board-meetingsQuarterly Results, Nine Months Results
11 Nov 2025board-meetingsQuarterly Results
20 Jun 2025agm
28 Jun 2024agm
23 Aug 2023agm
01 Jul 2022dividendAnnual General Meeting/Dividend - Rs 4 Per Share03 Aug 2022
28 Jun 2022agm
27 May 2022dividend₹4.00 Dividend /Share03 Aug 2022
22 Jun 2021agm
22 Jun 2021dividendAnnual General Meeting/Dividend - Rs 4 Per Share26 Jul 2021

Read More

Peer Comparison

Unichem Laboratories Ltd logo

Unichem Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Unichem Laboratories Ltd About

Unichem Laboratories is engaged in manufacturing of pharmaceutical products.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1962

Headquarters

CEO

Prakash A Mody

Employees

Contact

Website icon

Website

http://www.unichemlabs.com

Email icon

Email

shares@unichemlabs.com

Phone icon

Phone

91-22-66474100

Location icon

Location

47 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, 400067

Read More

Unichem Laboratories Ltd Company History

YearHistory
2019
  • Strategic investment in Hyderabad based Optimus Drugs Pvt Ltd. & Optrix Laboratories Pvt Ltd.
  • New plant site acquired in Goa
  • Product facility expansions in Ghaziabad and Pithampur
2020
  • Unichem Laboratories gets USFDA nod to market generic version of tolterodine tartrate tablets.
2021
  • Unichem Laboratories receives USFDA approval for Aripiraprazole tablets.
  • Unichem Laboratories receives USFDA approval for Zonisamide Capsules.
  • Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drug.
  • New Oral Solid Dosage manufacturing facility commissioned at Goa Plant II.
2022
  • Unichem Laboratories receives ANDA approval for Extended Phenytoin Sodium Capsules.
  • Unichem Labs gets US FDA nod for Schizophrenia drug.
2023
  • Ipca Laboratories Limited acquires 52.67% of the paid-up share capital of Unichem.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
IPCA LABORATORIES LIMITEDBuy23501440402.2502 Aug 2023
PRAKASH AMRUT MODYSell23501440402.2502 Aug 2023
SMC GLOBAL SECURITIES LTD.Sell520060379.4114 Feb 2018
SMC GLOBAL SECURITIES LTD.Buy395005379.5214 Feb 2018
NORDEA 1 SICAV INDIAN EQUITY FUND N2239LUASell540562379.2614 Feb 2018
PRAKASH AMRUT MODYBuy955000213.3818 Mar 2014
ANITA PRAKASH MODYSell955000213.3818 Mar 2014
BAJAJ ALLIANZ LIFE INSURANCE CO. LTDBuy200000306.1123 Dec 2009
PRIVATBANK IHAG ZURICH AGBuy22827614320 Feb 2009
MERRILL LYNCH CAPITAL MARKETS ESPANA S.A. SVBSell22827614320 Feb 2009

Read More

Unichem Laboratories Ltd News

Unichem US Unit Recalls Buspirone Tablets

Unichem Laboratories' US subsidiary voluntarily recalls Buspirone Hydrochloride Tablets due to out-of-specification assay results at 12-month stability testing.

13 Apr 2026

companies

Unichem US Unit Recalls Buspirone Tablets

Unichem Laboratories' US subsidiary voluntarily recalls Buspirone Hydrochloride Tablets due to out-of-specification assay results at 12-month stability testing.

12 Apr 2026

companies

Unichem Labs Gets [ICRA]A+ Rating Reaffirmed

ICRA reaffirms [ICRA]A+ stable rating for Unichem Laboratories' Rs. 180 crores bank facilities, covering fund-based, non-fund based and unallocated limits across multiple banking partners.

10 Apr 2026

companies

Unichem Labs Files Q4 FY26 Compliance Certificate

Unichem Laboratories submits SEBI compliance certificate for quarter ended March 31, 2026, confirming adherence to depositories and participants regulations through registrar Link Intime.

07 Apr 2026

companies

Unichem Labs Postal Ballot Results Approved

Unichem Laboratories shareholders approved three key resolutions through postal ballot including appointment of independent director Dr. Swati Patankar and material related party transactions with Unichem USA.

30 Mar 2026

companies

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800